Photo from Paolo Tarantino/X
May 31, 2024, 15:41
Paolo Tarantino: More than 25 ASCO24 oral presentations by Dana-Farber Cancer Institute researchers
Paolo Tarantino shared a post by Dana-Farber Cancer Institute on X:
“More than 25 ASCO24 oral presentations by Dana-Farber Cancer Institute researchers, including Antonio Giordano presenting on the Nectin4 ADC enfortumab vedotin for metastatic breast cancer and Ana Garrido-Castro presenting the first randomized Topo1 ADC-IO trial in breast oncology!” .
Quoting Dana-Farber Cancer Institute’s post:
“Heading to ASCO24? There are more than 25 oral presentations that are Dana-Farber researcher lead. Check out the list and follow Dana Farber News for full conference coverage.”
Source: Paolo Tarantino/X and Dana-Farber Cancer Institute/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 19, 2024, 10:18
Nov 19, 2024, 10:05
Nov 19, 2024, 09:53
Nov 19, 2024, 09:44
Nov 19, 2024, 09:40
Nov 19, 2024, 09:28